A NOD2/CARD15 carrier rate of 32% among CD Bedouin patients was reported, 47.4% among Ashkenazi Jewish CD patients, 27.4% among Sephardic Jews [7,12], and 7–16% among Caucasian CD patients [13]. This evidence concerns the gene NOD2 and Cowden disease.